Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -12.43 % |
3 Month Return | -30.58 % |
1 Year Return | -27.04 % |
Market Stats | |
Previous Close | ₹14.10 |
Open | ₹14.48 |
Volume | 3.32L |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹325.25Cr |
P/E Ratio | 19.86 |
PEG Ratio | 141.87 |
Market Cap | ₹325.25 Cr |
P/B Ratio | 2.18 |
EPS | 0.58 |
Dividend Yield | 0 |
Sector | Pharmaceuticals |
ROE | 9.45 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹325.25 Cr | 88.75% | 0.51 | ₹13 Cr | ₹86 Cr | |
NA | ₹973.98 Cr | 34.4% | 0.51 | NA | NA | |
NA | ₹586.27 Cr | -3.29% | 0.57 | ₹9 Cr | ₹179 Cr | |
NA | ₹12.94 Cr | 13.85% | 0.69 | NA | NA | |
NA | ₹131.64 Cr | 1.73% | 0.60 | NA | NA |
Organisation | Gennex Laboratories Ltd |
Headquarters | Hyderabad |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
Revenue is up for the last 2 quarters, 30.79 Cr → 33.38 Cr (in ₹), with an average increase of 7.8% per quarter
Profit Spike
Netprofit is up for the last 4 quarters, 2.76 Cr → 5.37 Cr (in ₹), with an average increase of 18.4% per quarter
Promoter Holding Unchanged
Promoters holdings remained unchanged at 18.42% of holdings in Dec 2024 quarter
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 151.6% return, outperforming this stock by 98.8%
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 58.2% return, outperforming this stock by 84.9%
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 81.58% of holdings in Dec 2024 quarter
Price Dip
In the last 3 months, Gennex Lab. stock has moved down by -30.2%
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 18.42% | 0.00 | |
Foreign Institutions | 0% | 0.00 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 81.58% | 0.00 | |
Others | 0% | 0.00 |
Gennex Laboratories Ltd in the last 5 years
Lowest (10.10x)
March 23, 2020
Today (19.86x)
January 30, 2025
Industry (53.04x)
January 30, 2025
Highest (86.13x)
August 3, 2018
Gennex Laboratories Ltd’s net profit jumped 74.92% since last year same period to ₹5.37Cr in the Q2 2024-2025. On a quarterly growth basis, Gennex Laboratories Ltd has generated 15.24% jump in its net profits since last 3-months.
Read More about Earnings ResultsBearish
Neutral
Bullish
Gennex Laboratories Ltd is currently in a Bearish trading position according to technical analysis indicators.
Gennex Laboratories Ltd share price today stands at ₹14.3, Open: ₹14.48, Previous Close: ₹14.1, High: ₹14.74, Low: ₹14.11, 52 Week High: ₹29, 52 Week Low: ₹13.13.
Gennex Laboratories Ltd is not listed on NSE
Gennex Laboratories Ltd is listed on BSE
Today's traded volume of Gennex Laboratories Ltd(531739) is 3.32L.
Today's market capitalisation of Gennex Laboratories Ltd(531739) is ₹325.25Cr.
Gennex Laboratories Ltd (531739) share price is ₹14.3. It is down -50.69% from its 52 Week High price of ₹29
Gennex Laboratories Ltd (531739) share price is ₹14.3. It is up 8.91% from its 52 Week Low price of ₹13.13
PE Ratio of Gennex Laboratories Ltd is 19.86
PE ratio = Gennex Laboratories Ltd Market price per share / Gennex Laboratories Ltd Earnings per share